Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

Recombinant of intelligent adenovirus vector and khp53 gene and application thereof

A technology of p53 gene and viral vector, which is applied in the field of genetic engineering, can solve problems such as difficult to pre-estimate the titer and yield of adenoviral vector, and achieve the effect of wide host range, good safety and low pathogenicity

Inactive Publication Date: 2010-08-11
BEIJING QIANJING LIKANG GENE TECH
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Therefore, it is difficult to estimate the titer and yield of a certain strain of adenovirus vector in advance

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Recombinant of intelligent adenovirus vector and khp53 gene and application thereof
  • Recombinant of intelligent adenovirus vector and khp53 gene and application thereof
  • Recombinant of intelligent adenovirus vector and khp53 gene and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0040] Example 1: Construction of recombinant khp53 tumor suppressor gene smart adenovirus

[0041] 1) Acquisition of the human p53 tumor suppressor gene coding sequence (abbreviated as khp53) with the Kozak rule sequence: two primers were designed and synthesized according to the published human wild-type p53 cDNA sequence, the upstream primer 5'-ATA GGATCC A CCATGGAGG AGC CGC AGT C 3', downstream primer 5' -ATA GGATCC ATG TCA GTC TGA GTC AG 3', (both upstream and downstream primers insert the BamHI restriction site GGATCC and restriction base ATA, and the upstream primer BamHI enzyme An A base is added after the cutting site GGATCC, and finally the sequence after the first two bases CC of the start codon ATG in the human p53 cDNA, that is, CCATGG AGG AGC CGC AGT C, so that the BamHI restriction site GGATCC The CC base, the added A base and the own CCATGG in the human p53 cDNA constitute the Kozak regular sequence CCACCATGG), using the human p53 cDNA as a template, using TaKa...

Embodiment 2

[0045] Example 2: Identification, cloning, massive amplification, purification and preparation of clinical-grade gene drug preparations of recombinant khp53 tumor suppressor gene smart adenovirus

[0046] 1) Identification of recombinant khp53 tumor suppressor gene intelligent adenovirus: with upstream primer: 5'-TCG TTT CTC AGC AGCTGT TG 3', downstream primer: 5'-CAT CTG AAC TCA AAG CGT GG 3', PCR amplification of Ad5 genome Specific fragment (11-13.4mu, 860bp) to identify whether the produced virus is type 5 adenovirus; use upstream primer 5'-AGCACTGTCC AACAACACCA 3', downstream primer 5'-ATA GGATCC ATG TCA GTC TGA GTC AG 3', PCR A 277 bp specific fragment in the coding region of the human p53 tumor suppressor gene was amplified to identify whether the human p53 tumor suppressor gene was inserted into the type 5 adenovirus. The results are shown in Figure 5, a total of 6 clones, all of which were type 5 adenovirus , and both carry the human p53 tumor suppressor gene.

[004...

Embodiment 3

[0050] Example 3: Titer determination of recombinant khp53 tumor suppressor gene smart adenovirus, determination of the number of adenovirus particles and gene expression analysis in human malignant tumor cells

[0051] 1) The TCID50 method was used to determine the titer of recombinant adenovirus: 293IQ cells were prepared with MEM culture medium at a concentration of 1×10 5 The suspension of cells / ml was inoculated in 96-well plate at 100 μl / well; at the same time, virus dilutions were prepared according to 10-fold dilution to infect the above cells respectively, and 100 μl of the same concentration of virus dilutions were added to the first 10 wells of each row. An equal volume of 2% BCS MEM was added to 12 wells as a negative control. 37°C, CO 2 Cultivate in the incubator for 10 days, observe under an inverted microscope, judge and record the CPE situation, and finally calculate the titer of the recombinant adenovirus according to the formula, T=10 1+d(S-0.5) IU / ml, wher...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
diameteraaaaaaaaaa
Login to View More

Abstract

The invention belongs to the field of genetic engineering techniques disclosing the recombinant and application of intelligent adenovirus vector and khp53 anti-oncogene. The invention specifically involves recombinant viral vector of human tumor-suppressing gene, especially involves human p53 tumor-suppressing gene recombination intellectual adenovirus vector conducted by Kozak sequence, and alsoinvolves drug combinations with the gene recombinant vector. Through the combination utilization of elements enhancing eukaryotic gene expression such as MCMV promoter, intron and Kozak regular sequence etc, the problem of relative shortage expression of the p53 gene is solved; and through adopting AdMAX HiIQ recombinant adenovirus vector system, the problem of effective packaging exogenous gene high expressing the recombined adenovirus effectively, and finally,through site-specific homologous recombination in eukaryotic cells, 5-recombinated adenovirus rAdMH-khp53 with E1, E3 deleted is packaged out. Utilizing recombinant adenovirus of the invention, clinical-used gene drugs can be prepared for prevention and treatment of a variety of cancer.

Description

Technical field: [0001] The invention belongs to the technical field of genetic engineering, and specifically relates to a recombinant virus vector of human tumor suppressor gene, in particular to a human p53 tumor suppressor gene recombinant intelligent adenoviral vector guided by Kozak sequence, and also relates to a drug combination containing the gene recombinant vector things. Background technique: [0002] 1. Tumor gene therapy [0003] Gene therapy is to introduce therapeutic genes or DNA (RNA) fragments into human target cells in a certain way, aiming at various molecular pathological changes that cause diseases, and correspondingly regulates the expression of genes at the molecular level, so as to play a therapeutic role and achieve Molecular medical treatments aimed at fundamentally treating disease. [0004] Over the past decade, tumor gene therapy has developed rapidly. Since 1995, the United States has successively established 10 major gene therapy companies....

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C12N15/861C12N15/12A61K48/00A61P35/00
Inventor 谢庆军
Owner BEIJING QIANJING LIKANG GENE TECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com